Juvenile myelomonocytic leukemia: A report from the 2nd International JMML Symposium

Rebecca Chan, Todd Cooper, Christian P. Kratz, Brian Weiss, Mignon L. Loh

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Juvenile myelomonocytic leukemia (JMML) is an aggressive childhood myeloproliferative disorder characterized by the overproduction of myelomonocytic cells. JMML incidence approaches 1.2/million persons in the United States (Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995). Although rare, JMML is innately informative as the molecular genetics of this disease implicates hyperactive Ras as an essential initiating event. Given that Ras is one of the most frequently mutated oncogenes in human cancer, findings from this disease are applicable to more genetically diverse and complex adult leukemias. The JMML Foundation (www.jmmlfoundation.org) was founded by parent advocates dedicated to finding a cure for this disease. They work to bring investigators together in a collaborative manner. This article summarizes key presentations from The Second International JMML Symposium, on 7-8 December 2007 in Atlanta, GA. A list of all participants is in Supplementary Table.

Original languageEnglish
Pages (from-to)355-362
Number of pages8
JournalLeukemia Research
Volume33
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Juvenile Myelomonocytic Leukemia
SEER Program
Myeloproliferative Disorders
Inborn Genetic Diseases
Incidence
Oncogenes
Molecular Biology
Neoplasms
Leukemia
Research Personnel
Survival

Keywords

  • Diagnosis
  • Juvenile myelomonocytic leukemia (JMML)
  • NF1
  • PTPN11
  • RAS
  • Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Juvenile myelomonocytic leukemia : A report from the 2nd International JMML Symposium. / Chan, Rebecca; Cooper, Todd; Kratz, Christian P.; Weiss, Brian; Loh, Mignon L.

In: Leukemia Research, Vol. 33, No. 3, 03.2009, p. 355-362.

Research output: Contribution to journalArticle

Chan, Rebecca ; Cooper, Todd ; Kratz, Christian P. ; Weiss, Brian ; Loh, Mignon L. / Juvenile myelomonocytic leukemia : A report from the 2nd International JMML Symposium. In: Leukemia Research. 2009 ; Vol. 33, No. 3. pp. 355-362.
@article{3c3a05d6bf6b45468a63062ed1d55ea3,
title = "Juvenile myelomonocytic leukemia: A report from the 2nd International JMML Symposium",
abstract = "Juvenile myelomonocytic leukemia (JMML) is an aggressive childhood myeloproliferative disorder characterized by the overproduction of myelomonocytic cells. JMML incidence approaches 1.2/million persons in the United States (Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995). Although rare, JMML is innately informative as the molecular genetics of this disease implicates hyperactive Ras as an essential initiating event. Given that Ras is one of the most frequently mutated oncogenes in human cancer, findings from this disease are applicable to more genetically diverse and complex adult leukemias. The JMML Foundation (www.jmmlfoundation.org) was founded by parent advocates dedicated to finding a cure for this disease. They work to bring investigators together in a collaborative manner. This article summarizes key presentations from The Second International JMML Symposium, on 7-8 December 2007 in Atlanta, GA. A list of all participants is in Supplementary Table.",
keywords = "Diagnosis, Juvenile myelomonocytic leukemia (JMML), NF1, PTPN11, RAS, Therapy",
author = "Rebecca Chan and Todd Cooper and Kratz, {Christian P.} and Brian Weiss and Loh, {Mignon L.}",
year = "2009",
month = "3",
doi = "10.1016/j.leukres.2008.08.022",
language = "English",
volume = "33",
pages = "355--362",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Juvenile myelomonocytic leukemia

T2 - A report from the 2nd International JMML Symposium

AU - Chan, Rebecca

AU - Cooper, Todd

AU - Kratz, Christian P.

AU - Weiss, Brian

AU - Loh, Mignon L.

PY - 2009/3

Y1 - 2009/3

N2 - Juvenile myelomonocytic leukemia (JMML) is an aggressive childhood myeloproliferative disorder characterized by the overproduction of myelomonocytic cells. JMML incidence approaches 1.2/million persons in the United States (Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995). Although rare, JMML is innately informative as the molecular genetics of this disease implicates hyperactive Ras as an essential initiating event. Given that Ras is one of the most frequently mutated oncogenes in human cancer, findings from this disease are applicable to more genetically diverse and complex adult leukemias. The JMML Foundation (www.jmmlfoundation.org) was founded by parent advocates dedicated to finding a cure for this disease. They work to bring investigators together in a collaborative manner. This article summarizes key presentations from The Second International JMML Symposium, on 7-8 December 2007 in Atlanta, GA. A list of all participants is in Supplementary Table.

AB - Juvenile myelomonocytic leukemia (JMML) is an aggressive childhood myeloproliferative disorder characterized by the overproduction of myelomonocytic cells. JMML incidence approaches 1.2/million persons in the United States (Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995). Although rare, JMML is innately informative as the molecular genetics of this disease implicates hyperactive Ras as an essential initiating event. Given that Ras is one of the most frequently mutated oncogenes in human cancer, findings from this disease are applicable to more genetically diverse and complex adult leukemias. The JMML Foundation (www.jmmlfoundation.org) was founded by parent advocates dedicated to finding a cure for this disease. They work to bring investigators together in a collaborative manner. This article summarizes key presentations from The Second International JMML Symposium, on 7-8 December 2007 in Atlanta, GA. A list of all participants is in Supplementary Table.

KW - Diagnosis

KW - Juvenile myelomonocytic leukemia (JMML)

KW - NF1

KW - PTPN11

KW - RAS

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=58549090093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58549090093&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2008.08.022

DO - 10.1016/j.leukres.2008.08.022

M3 - Article

C2 - 18954903

AN - SCOPUS:58549090093

VL - 33

SP - 355

EP - 362

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 3

ER -